Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. Soc. Bras. Med. Trop ; 53: e20200225, 2020. tab, graf
Article in English | SES-SP, ColecionaSUS, LILACS | ID: biblio-1136876

ABSTRACT

Abstract INTRODUCTION: Patients with Chagas disease (CD), caused by Trypanosoma cruzi, present a higher risk of developing other chronic diseases, which may contribute to CD severity. Since CD is underreported in the southern state of Paraná, Brazil, we aimed to characterize clinical and epidemiological aspects of individuals chronically infected with T. cruzi in Southern Brazil. METHODS: A community hospital-based study was performed, recording clinical/demographic characteristics of 237 patients with CD from Southern Brazil. To estimate the association between different forms of CD and sociodemographic and clinical variables, multiple logistic regression models were built using the Akaike information criterion. RESULTS: Mean age was 57.5 years and 59% were females. Most patients' (60%) place of origin/birth was within Paraná and they were admitted to the CD outpatient clinic after presenting with cardiac/digestive symptoms (64%). The predominant form of CD was cardiac (53%), followed by indeterminate (36%), and digestive (11%). The main electrocardiographic changes were in the right bundle branch block (39%) and left anterior fascicular block (32%). The average number of comorbidities per patient was 3.9±2.3; systemic arterial hypertension was most common (64%), followed by dyslipidemia (34%) and diabetes (19%); overlapping comorbidities were counted separately. Male sex was associated with symptomatic cardiac CD (OR=2.92; 95%CI: 1.05-8.12; p=0.040). CONCLUSIONS: This study provided greater understanding of the distribution and clinical profile of CD patients in Southern Brazil, indicating a high prevalence of comorbidities among these patients who are a vulnerable group due to advanced age and substantial risk of morbidity.


Subject(s)
Humans , Male , Female , Trypanosoma cruzi , Chagas Disease/diagnosis , Chagas Disease/epidemiology , Brazil/epidemiology , Chronic Disease , Prevalence , Middle Aged
2.
Braz. j. infect. dis ; 5(6): 313-318, dec. 2001.
Article in English | LILACS | ID: lil-331045

ABSTRACT

Fungal urinary tract infections are an increasing problem in hospitalized patients. Funguria may be a result of contamination of the urine specimen, colonization of hte urinary tract, or may be indicative of true invasive infection. In this study, we report the risk factors, clinical features, treatments and outcome in a group of 68 hospitalized patients (adults and children) with fungal isolates recovered from 103 urinary samples. Underlying medical conditions were present in most patients. In the pediatric group, urinary tract abnormalities (86) and prematurity (19)accounted for the majority of the cases. Diabetes mellitus (28), nephrolithiasis, and benign prostatic hyperplasia were the most common diseases in adults. Indwelling urethral catheters were noted in 38 of the pediatric patients and in 43 of adults during hospitalization. Candida albicans strains were responsible for 97 and 75 of positive cultures in children and adults, respectively. Symptoms such as fever, dysuria, frequency and flank pain were generally absent in both groups. Fluconazole was the most frequent antifungal utilized (61) in children and ketoconazole in the adult group (42). Removing the urinary catheter was attempted in 6 pediatric patients (29) and in only 8 adults (17). One patient (4) in the pediatric group died compared to 10 in the adult group (21, p=0.04). Successful diagnosis and treatment of funguria depends on a clear understanding of the risk factors and awareness of fungal epidemiology.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Antifungal Agents/therapeutic use , Fungi , Hospitalization , Mycoses , Urinary Tract Infections , Aged, 80 and over , Candida albicans , Candidiasis/drug therapy , Candidiasis/epidemiology , Candidiasis/microbiology , Candidiasis/physiopathology , Culture Media , Fungi , Urinary Tract Infections/drug therapy , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology , Urinary Tract Infections/physiopathology , Mycoses , Risk Factors , Treatment Outcome , Urine
SELECTION OF CITATIONS
SEARCH DETAIL